オプションチェーンは、Confluentの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Confluentの市場センチメントを評価します。.

Confluent (NASDAQ:CFLT) 株価情報, オプションチェーン

Confluent

Confluent Inc is a new category of data infrastructure designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. Its products include Confluent Platform; Connectors; ksqlDB and others. The company generates revenue from the sale of subscriptions and services. Geographically, it derives a majority of its revenue from the United States. The company provides solutions to Financial Services; Insurance; Retail and eCommerce; Automotive; Government and other sectors.

Confluent Inc

<p>The Q4 earnings report for <strong>DHI Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHX#NYSE">DHX</a>) was released on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>DHI Group beat estimated earnings by 0.07%, reporting an EPS of $0.07 versus an estimate of $0.0.</p>
<p>Revenue was down $2.50 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>Last quarter the company beat on EPS by $0.02 which was followed by a 7.000000000000001% drop in the share price the next day.</p>
<p>Here's a look at DHI Group's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.03</td>
<td>0.03</td>
<td>0.02</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.05</td>
<td>0.06</td>
<td>0.05</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>35.27M</td>
<td>36.09M</td>
<td>36.36M</td>
<td>35.79M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>35.28M</td>
<td>35.83M</td>
<td>36.02M</td>
<td>37.29M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for DHI Group <a href="https://www.benzinga.com/quote/DHX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings

DHI Group Q4 Earnings Report: What Investors Need to Know

<p>The earnings results for <strong>MetLife</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) for Q4 were made public on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>MetLife missed estimated earnings by 0.0%, reporting an EPS of $2.09 versus an estimate of $2.09.</p>
<p>Revenue was up $1.02 billion from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>The company missed on EPS by $0.22 in the last quarter, resulting in a 6.0% drop share price change the following day.</p>
<p>Here's a look at MetLife's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.17</td>
<td>2.17</td>
<td>1.83</td>
<td>1.89</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.95</td>
<td>2.28</td>
<td>1.83</td>
<td>1.83</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>18.66B</td>
<td>18.24B</td>
<td>17.72B</td>
<td>18.46B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>17.61B</td>
<td>18.68B</td>
<td>17.02B</td>
<td>18.72B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for MetLife <a href="https://www.benzinga.com/quote/MET/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Summary: MetLife Q4

<p><strong>Omega Healthcare Invts</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OHI#NYSE">OHI</a>) reported its Q4 earnings results on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>Omega Healthcare Invts beat estimated earnings by 1.0%, reporting an EPS of $0.74 versus an estimate of $0.73.</p>
<p>Revenue was up $40.00 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>The company beat on EPS by $0.03 in the previous quarter, leading to a 0.0% increase share price change the next day.</p>
<p>Here's a look at Omega Healthcare Invts's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.71</td>
<td>0.68</td>
<td>0.65</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.74</td>
<td>0.71</td>
<td>0.68</td>
<td>0.68</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>261.64M</td>
<td>246.73M</td>
<td>231.64M</td>
<td>233.82M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>276.03M</td>
<td>252.75M</td>
<td>243.30M</td>
<td>239.32M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Omega Healthcare Invts management provided guidance for FY 2025, expecting earnings between $2.9 and $2.98 per share.</p>
<p>To track all earnings releases for Omega Healthcare Invts <a href="https://www.benzinga.com/quote/OHI/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Breakdown: Omega Healthcare Invts Q4

<p>The Q4 earnings report for <strong>Mid-America Apartment</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAA#NYSE">MAA</a>) was released on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Mid-America Apartment missed estimated earnings by -0.0%, reporting an EPS of $2.23 versus an estimate of $2.24.</p>
<p>Revenue was up $7.58 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>The company beat on EPS by $0.03 in the last quarter, resulting in a 1.0% drop share price change the following day.</p>
<p>Here's a look at Mid-America Apartment's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.18</td>
<td>2.20</td>
<td>2.22</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.21</td>
<td>2.22</td>
<td>2.22</td>
<td>2.32</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>549.38M</td>
<td>545.41M</td>
<td>542.72M</td>
<td>542.77M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>551.13M</td>
<td>546.43M</td>
<td>543.62M</td>
<td>542.25M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Mid-America Apartment management provided guidance for Q1 2025, expecting earnings between $2.08 and $2.24 per share.</p>
<p>To track all earnings releases for Mid-America Apartment <a href="https://www.benzinga.com/quote/MAA/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Mid-America Apartment Earnings Report: Q4 Overview

<p>KOMET-001 registrational trial in R/R NPM1-m AML achieved primary CR/CRh endpoint; topline data submitted for presentation at an upcoming medical meeting –</p>
<p>– NDA submission for ziftomenib on track for 2Q 2025 –</p>
<p>– Registrational KOMET-017-IC trial of intensive chemotherapy combination will assess MRD negative CR and EFS as dual-primary endpoints to support potential U.S. accelerated approval and full approval –</p>
<p>– Registrational KOMET-017-NIC trial of venetoclax / azacitidine combination will assess CR and OS as dual-primary endpoints to support potential U.S. accelerated approval and full approval –</p>
<p>– KOMET-017-IC and NIC Phase 3 trials expected to initiate in 2H 2025 –</p>
<p>– Multiple clinical data presentations for ziftomenib and pipeline programs anticipated throughout 2025 –</p>


Biotech

News

General

KURA

Kura Oncology And Kyowa Kirin Announce Ziftomenib Monotherapy Registrational Trial And FDA Feedback For Upcoming Frontline Combination Trial Designs

<p><strong>Lesaka Technologies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSAK#NASDAQ">LSAK</a>) just disclosed its Q2 earnings on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Lesaka Technologies missed estimated earnings by 0.0%, reporting an EPS of $0.01 versus an estimate of $0.01.</p>
<p>Revenue was up $2.92 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>During the previous quarter, the company beat on EPS by $0.08, leading to a 3.0% drop share price change the next day.</p>
<p>Here's a look at Lesaka Technologies's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.04</td>
<td>-0.06</td>
<td>-0.04</td>
<td>-0.03</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.04</td>
<td>0.02</td>
<td>0.02</td>
<td>0.01</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>144.16M</td>
<td>149.30M</td>
<td>145.53M</td>
<td>144.47M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>145.55M</td>
<td>146.05M</td>
<td>138.19M</td>
<td>143.89M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Lesaka Technologies <a href="https://www.benzinga.com/quote/LSAK/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


LSAK

Insights into Lesaka Technologies Q2 Earnings

<p><strong>Paycor HCM</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYCR#NASDAQ">PYCR</a>) released its Q2 earnings on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Paycor HCM beat estimated earnings by 17.0%, reporting an EPS of $0.14 versus an estimate of $0.12.</p>
<p>Revenue was up $20.90 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>Last quarter the company beat on EPS by $0.02 which was followed by a 3.0% increase in the share price the next day.</p>
<p>Here's a look at Paycor HCM's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.08</td>
<td>0.09</td>
<td>0.20</td>
<td>0.09</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.10</td>
<td>0.11</td>
<td>0.21</td>
<td>0.11</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>162.17M</td>
<td>161.17M</td>
<td>186.44M</td>
<td>155.59M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>167.48M</td>
<td>164.80M</td>
<td>187.02M</td>
<td>159.54M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Paycor HCM <a href="https://www.benzinga.com/quote/PYCR/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


PYCR

Paycor HCM Earnings Report: Q2 Overview

<p><strong>News</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWSA#NASDAQ">NWSA</a>) announced its Q2 earnings on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>News beat estimated earnings by 3.0%, reporting an EPS of $0.33 versus an estimate of $0.32.</p>
<p>Revenue was down $348.00 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>During the previous quarter, the company beat on EPS by $0.05, leading to a 1.0% increase share price change the next day.</p>
<p>Here's a look at News's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.16</td>
<td>0.14</td>
<td>0.11</td>
<td>0.19</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.21</td>
<td>0.17</td>
<td>0.11</td>
<td>0.26</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>2.56B</td>
<td>2.47B</td>
<td>2.46B</td>
<td>2.55B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>2.58B</td>
<td>2.58B</td>
<td>2.42B</td>
<td>2.59B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for News <a href="https://www.benzinga.com/quote/NWSA/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


NWSA

Earnings Breakdown: News Q2

<p>Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) reported quarterly earnings of $1.18 per share which beat the analyst consensus estimate of $0.48 by 145.83 percent. This is a 2066.67 percent increase over losses of $(0.06) per share from the same period last year.  The company reported quarterly sales of $438.72 million which beat the analyst consensus estimate of $340.62 million by 28.80 percent.  This is a 104.17 percent increase over sales of $214.88 million the same period last year.</p>


Earnings Beats

Moelis Q4 Adj EPS $1.18 Beats $0.48 Estimate, Sales $438.72M Beat $340.62M Estimate

<p><strong>Rayonier</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYN#NYSE">RYN</a>) just disclosed its Q4 earnings on Wednesday, February 5, 2025 at 04:20 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Rayonier beat estimated earnings by 35.0%, reporting an EPS of $0.27 versus an estimate of $0.2.</p>
<p>Revenue was up $258.90 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>The company missed on EPS by $0.01 in the previous quarter, leading to a 1.0% increase share price change the next day.</p>
<p>Here's a look at Rayonier's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.13</td>
<td>0.13</td>
<td>0.04</td>
<td>0.15</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.12</td>
<td>0.02</td>
<td>0.05</td>
<td>0.17</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>210.86M</td>
<td>220.04M</td>
<td>193.67M</td>
<td>229.75M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>195.00M</td>
<td>173.60M</td>
<td>168.10M</td>
<td>467.40M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Rayonier management provided guidance for FY 2025, expecting earnings between $0.51 and $0.64 per share.</p>
<p>To track all earnings releases for Rayonier <a href="https://www.benzinga.com/quote/RYN/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Rayonier Q4 Earnings Summary & Key Takeaways

<p><strong>LiveRamp Holdings</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RAMP#NYSE">RAMP</a>) announced its Q3 earnings on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>LiveRamp Holdings beat estimated earnings by 20.0%, reporting an EPS of $0.55 versus an estimate of $0.46.</p>
<p>Revenue was up $21.54 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>The company beat on EPS by $0.14 in the last quarter, resulting in a 8.0% increase share price change the following day.</p>
<p>Here's a look at LiveRamp Holdings's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.37</td>
<td>0.31</td>
<td>0.19</td>
<td>0.40</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.51</td>
<td>0.35</td>
<td>0.25</td>
<td>0.47</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>176.04M</td>
<td>171.91M</td>
<td>160.62M</td>
<td>172.54M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>154.07M</td>
<td>175.96M</td>
<td>171.85M</td>
<td>173.87M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for LiveRamp Holdings <a href="https://www.benzinga.com/quote/RAMP/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


RAMP

Earnings Summary: LiveRamp Holdings Q3

<p>The Q4 earnings report for <strong>Regional Mgmt</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RM#NYSE">RM</a>) was released on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Regional Mgmt beat estimated earnings by 10.0%, reporting an EPS of $0.98 versus an estimate of $0.89.</p>
<p>Revenue was up $13.17 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company missed on EPS by $0.29 in the last quarter, resulting in a 6.0% drop share price change the following day.</p>
<p>Here's a look at Regional Mgmt's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.05</td>
<td>0.58</td>
<td>0.88</td>
<td>0.43</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.76</td>
<td>0.86</td>
<td>1.56</td>
<td>0.54</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>144.37M</td>
<td>138.83M</td>
<td>139.58M</td>
<td>141.95M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>146.34M</td>
<td>143.03M</td>
<td>144.31M</td>
<td>141.66M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Regional Mgmt <a href="https://www.benzinga.com/quote/RM/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Regional Mgmt Q4 Earnings Report: What Investors Need to Know

<p>The Q3 earnings report for <strong>ARM Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) was released on Wednesday, February 5, 2025 at 04:04 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>ARM Holdings beat estimated earnings by 15.0%, reporting an EPS of $0.39 versus an estimate of $0.34.</p>
<p>Revenue was up $159.00 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>During the previous quarter, the company beat on EPS by $0.04, leading to a 4.0% increase share price change the next day.</p>
<p>Here's a look at ARM Holdings's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.26</td>
<td>0.34</td>
<td>0.30</td>
<td>0.25</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.30</td>
<td>0.40</td>
<td>0.36</td>
<td>0.29</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>808.37M</td>
<td>903.57M</td>
<td>875.62M</td>
<td>761.62M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>844.00M</td>
<td>939.00M</td>
<td>928.00M</td>
<td>824.00M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>ARM Holdings management provided guidance for Q4 2025, expecting earnings between $0.48 and $0.56 per share.</p>
<p>To track all earnings releases for ARM Holdings <a href="https://www.benzinga.com/quote/ARM/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ARM Holdings Earnings Report: Q3 Overview

<p><strong>Safehold</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAFE#NYSE">SAFE</a>) just disclosed its Q4 earnings on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Safehold missed estimated earnings by -3.0%, reporting an EPS of $0.36 versus an estimate of $0.37.</p>
<p>Revenue was down $11.13 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company missed on EPS by $0.0 in the last quarter, resulting in a 4.0% drop share price change the following day.</p>
<p>Here's a look at Safehold's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.37</td>
<td>0.36</td>
<td>0.39</td>
<td>0.35</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.37</td>
<td>0.41</td>
<td>0.43</td>
<td>0.36</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>90.41M</td>
<td>88.19M</td>
<td>88.08M</td>
<td>85.95M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>90.70M</td>
<td>89.89M</td>
<td>93.21M</td>
<td>103.00M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Safehold <a href="https://www.benzinga.com/quote/SAFE/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


SAFE

Safehold Q4 Earnings Assessment

WIIM

QCOM

Qualcomm shares are trading lower. The company reported Q1 financial results.

<p>The earnings results for <strong>Coherent</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) for Q2 were made public on Wednesday, February 5, 2025 at 04:14 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Coherent beat estimated earnings by 42.0%, reporting an EPS of $0.95 versus an estimate of $0.67.</p>
<p>Revenue was up $304.00 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>During the previous quarter, the company beat on EPS by $0.13, leading to a 10.0% increase share price change the next day.</p>
<p>Here's a look at Coherent's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.61</td>
<td>0.59</td>
<td>0.42</td>
<td>0.26</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.74</td>
<td>0.61</td>
<td>0.53</td>
<td>0.36</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.31B</td>
<td>1.28B</td>
<td>1.17B</td>
<td>1.12B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.35B</td>
<td>1.31B</td>
<td>1.21B</td>
<td>1.13B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Coherent management provided guidance for Q3 2025, expecting earnings between $0.75 and $0.95 per share.</p>
<p>To track all earnings releases for Coherent <a href="https://www.benzinga.com/quote/COHR/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


COHR

Earnings Breakdown: Coherent Q2

<p><strong>Unifi</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UFI#NYSE">UFI</a>) released its Q2 earnings on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Unifi missed estimated earnings by -56.00000000000001%, reporting an EPS of $-0.86 versus an estimate of $-0.55.</p>
<p>Revenue was up $1.96 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>During the previous quarter, the company missed on EPS by $0.17, leading to a 11.0% drop share price change the next day.</p>
<p>Here's a look at Unifi's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.25</td>
<td>-0.21</td>
<td>-0.42</td>
<td>-0.85</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.42</td>
<td>-0.22</td>
<td>-0.57</td>
<td>-0.81</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>148.01M</td>
<td>162.00M</td>
<td>151.13M</td>
<td>135.57M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>147.37M</td>
<td>157.45M</td>
<td>149.00M</td>
<td>136.92M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Unifi <a href="https://www.benzinga.com/quote/UFI/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Unifi Q2 Earnings Report: What Investors Need to Know

<p>The earnings results for <strong>First Industrial Realty</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FR#NYSE">FR</a>) for Q4 were made public on Wednesday, February 5, 2025 at 04:28 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>First Industrial Realty beat estimated earnings by 3.0%, reporting an EPS of $0.71 versus an estimate of $0.69.</p>
<p>Revenue was up $18.31 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>The company beat on EPS by $0.01 in the last quarter, resulting in a 2.0% drop share price change the following day.</p>
<p>Here's a look at First Industrial Realty's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.67</td>
<td>0.64</td>
<td>0.62</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.68</td>
<td>0.66</td>
<td>0.60</td>
<td>0.63</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>166.83M</td>
<td>163.57M</td>
<td>159.62M</td>
<td>156.70M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>167.65M</td>
<td>164.14M</td>
<td>162.27M</td>
<td>157.28M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>First Industrial Realty management provided guidance for FY 2025, expecting earnings between $2.87 and $2.97 per share.</p>
<p>To track all earnings releases for First Industrial Realty <a href="https://www.benzinga.com/quote/FR/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


First Industrial Realty Earnings Report: Q4 Overview

<p><strong>Accuray</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAY#NASDAQ">ARAY</a>) released its Q2 earnings on Wednesday, February 5, 2025 at 04:05 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Accuray beat estimated earnings by 150.0%, reporting an EPS of $0.02 versus an estimate of $-0.04.</p>
<p>Revenue was up $8.94 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>During the previous quarter, the company beat on EPS by $0.01, leading to a 3.0% increase share price change the next day.</p>
<p>Here's a look at Accuray's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.05</td>
<td>0.03</td>
<td>-0.01</td>
<td>-0.05</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.04</td>
<td>0.03</td>
<td>-0.06</td>
<td>-0.10</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>97.55M</td>
<td>121.51M</td>
<td>113.65M</td>
<td>106.67M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>101.55M</td>
<td>134.29M</td>
<td>101.13M</td>
<td>107.24M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Accuray <a href="https://www.benzinga.com/quote/ARAY/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ARAY

Accuray Q2 Earnings Summary & Key Takeaways

<p>Matrix Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTRX#NASDAQ">MTRX</a>) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.22) by 9.09 percent. This is a 11.11 percent decrease over losses of $(0.18) per share from the same period last year.  The company reported quarterly sales of $187.17 million which beat the analyst consensus estimate of $185.15 million by 1.09 percent.  This is a 6.93 percent increase over sales of $175.04 million the same period last year.</p>


MTRX

Matrix Service Q2 Adj EPS $(0.20) Beats $(0.22) Estimate, Sales $187.17M Beat $185.15M Estimate

Morgan Stanley downgraded Confluent (CFLT) to Equal Weight from Overweight with a price target of $30, down from $33. While the company's data stre...

Confluent downgraded to Equal Weight from Overweight at Morgan Stanley

Confluent slides on back of Morgan Stanley downgrade

Confluent: Excellent Growth At An Even Better Price

MongoDB added as 'top pick' due to generative-AI in 2025: Morgan Stanley

RBC Capital analyst Matthew Hedberg maintained a Buy rating on Confluent (CFLT – Research Report) on January 20 and set a price target of $36.00. T...

Confluent (CFLT) Receives a Rating Update from a Top Analyst

Confluent: A Disconnect That's Too Wide To Ignore

Snowflake in talks to acquire analytics startup Redpanda - report

Guggenheim raised the firm's price target on Confluent (CFLT) to $35 from $32 and keeps a Buy rating on the shares. The firm believes Confluent wil...

Confluent price target raised to $35 from $32 at Guggenheim

Tariffing Our Largest Trading Partners Hurting Stocks? Remember The Pain Trade

JMP Securities analyst Patrick Walravens maintained a Buy rating on Confluent (CFLT – Research Report) today and set a price target of $40.00. The ...

Comments

Confluent

Confluent (CFLT) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル